Pulmonx (LUNG) Interest & Investment Income (2019 - 2025)
Pulmonx's (LUNG) quarterly Interest & Investment Income came in at $611000.0 in Q3 2025, down 51.85% year-on-year from $1.3 million in Q3 2024, and down 15.49% on a QoQ basis from $723000.0 in Q2 2025.
Pulmonx (LUNG) Interest & Investment Income (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Interest & Investment Income data on file, last reported at $611000.0 in Q3 2025.
- On a quarterly basis, Interest & Investment Income fell 51.85% year-over-year to $611000.0 in Q3 2025; TTM through Sep 2025 was $3.2 million, a 41.64% decrease from a year earlier, with the FY2024 full-year figure at $5.1 million, down 9.11% from the prior year.
- Interest & Investment Income for Q3 2025 stood at $611000.0, down from $723000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for LUNG reached as high as $1.5 million in Q4 2023 and fell as low as $94000.0 in Q4 2021.
- Historically, Interest & Investment Income has averaged $776631.6 across 5 years, with a median of $748000.0 in 2022.
- Across the five-year window, Interest & Investment Income jumped 1000.0% in 2021 and sank 51.85% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $94000.0 in 2021, then soared by 695.74% to $748000.0 in 2022, then soared by 106.02% to $1.5 million in 2023, then sank by 32.19% to $1.0 million in 2024, then plunged by 41.53% to $611000.0 in 2025.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $611000.0 in Q3 2025, $723000.0 in Q2 2025, and $864000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Pulmonx | 50.56 Mn | -19.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 611,000.00 |
| Jun 30, 2025 | 723,000.00 |
| Mar 31, 2025 | 864,000.00 |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 748,000.00 |
| Sep 30, 2022 | 477,000.00 |
| Jun 30, 2022 | 199,000.00 |
| Mar 31, 2022 | 105,000.00 |
| Dec 31, 2021 | 94,000.00 |
| Sep 30, 2021 | 99,000.00 |
| Jun 30, 2021 | 102,000.00 |
| Mar 31, 2021 | 105,000.00 |
| Dec 31, 2020 | 115,000.00 |